1-65572385-G-T

Variant summary

Our verdict is Likely benign. The variant received -5 ACMG points: 0P and 5B. BP4_StrongBS1_Supporting

The NM_002303.6(LEPR):​c.430G>T​(p.Val144Leu) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000368 in 1,444,344 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 16/22 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).

Frequency

Genomes: 𝑓 0.00022 ( 0 hom., cov: 30)
Exomes 𝑓: 0.00038 ( 0 hom. )

Consequence

LEPR
NM_002303.6 missense

Scores

16

Clinical Significance

Uncertain significance criteria provided, single submitter U:2

Conservation

PhyloP100: 0.156

Publications

3 publications found
Variant links:
Genes affected
LEPR (HGNC:6554): (leptin receptor) The protein encoded by this gene belongs to the gp130 family of cytokine receptors that are known to stimulate gene transcription via activation of cytosolic STAT proteins. This protein is a receptor for leptin (an adipocyte-specific hormone that regulates body weight), and is involved in the regulation of fat metabolism, as well as in a novel hematopoietic pathway that is required for normal lymphopoiesis. Mutations in this gene have been associated with obesity and pituitary dysfunction. Alternatively spliced transcript variants encoding different isoforms have been described for this gene. It is noteworthy that this gene and LEPROT gene (GeneID:54741) share the same promoter and the first 2 exons, however, encode distinct proteins (PMID:9207021).[provided by RefSeq, Nov 2010]
LEPR Gene-Disease associations (from GenCC):
  • obesity due to leptin receptor gene deficiency
    Inheritance: AR Classification: STRONG, SUPPORTIVE Submitted by: Orphanet, Labcorp Genetics (formerly Invitae), Genomics England PanelApp

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Likely_benign. The variant received -5 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.030551732).
BS1
Variant frequency is greater than expected in population nfe. GnomAdExome4 allele frequency = 0.000384 (502/1305672) while in subpopulation NFE AF = 0.000463 (468/1011082). AF 95% confidence interval is 0.000428. There are 0 homozygotes in GnomAdExome4. There are 251 alleles in the male GnomAdExome4 subpopulation. Median coverage is 34. This position passed quality control check. Existence of Clinvar submissions makes me limit the strength of this signal to Supporting

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
LEPRNM_002303.6 linkc.430G>T p.Val144Leu missense_variant Exon 5 of 20 ENST00000349533.11 NP_002294.2

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
LEPRENST00000349533.11 linkc.430G>T p.Val144Leu missense_variant Exon 5 of 20 1 NM_002303.6 ENSP00000330393.7

Frequencies

GnomAD3 genomes
AF:
0.000216
AC:
30
AN:
138574
Hom.:
0
Cov.:
30
show subpopulations
Gnomad AFR
AF:
0.000161
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.000455
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.000244
Gnomad OTH
AF:
0.00104
GnomAD2 exomes
AF:
0.000158
AC:
39
AN:
247206
AF XY:
0.000135
show subpopulations
Gnomad AFR exome
AF:
0.000189
Gnomad AMR exome
AF:
0.000146
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.0000465
Gnomad NFE exome
AF:
0.000260
Gnomad OTH exome
AF:
0.000166
GnomAD4 exome
AF:
0.000384
AC:
502
AN:
1305672
Hom.:
0
Cov.:
34
AF XY:
0.000387
AC XY:
251
AN XY:
647984
show subpopulations
African (AFR)
AF:
0.000105
AC:
3
AN:
28584
American (AMR)
AF:
0.000201
AC:
8
AN:
39894
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
20394
East Asian (EAS)
AF:
0.00
AC:
0
AN:
26544
South Asian (SAS)
AF:
0.0000119
AC:
1
AN:
83868
European-Finnish (FIN)
AF:
0.0000994
AC:
4
AN:
40256
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
4850
European-Non Finnish (NFE)
AF:
0.000463
AC:
468
AN:
1011082
Other (OTH)
AF:
0.000359
AC:
18
AN:
50200
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.489
Heterozygous variant carriers
0
28
56
83
111
139
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Variant carriers
0
22
44
66
88
110
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.000216
AC:
30
AN:
138672
Hom.:
0
Cov.:
30
AF XY:
0.000136
AC XY:
9
AN XY:
66342
show subpopulations
African (AFR)
AF:
0.000160
AC:
6
AN:
37432
American (AMR)
AF:
0.000455
AC:
6
AN:
13198
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
3372
East Asian (EAS)
AF:
0.00
AC:
0
AN:
4326
South Asian (SAS)
AF:
0.00
AC:
0
AN:
4078
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
7644
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
252
European-Non Finnish (NFE)
AF:
0.000244
AC:
16
AN:
65544
Other (OTH)
AF:
0.00103
AC:
2
AN:
1938
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.492
Heterozygous variant carriers
0
2
3
5
6
8
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.000327
Hom.:
0
ESP6500AA
AF:
0.00
AC:
0
ESP6500EA
AF:
0.000584
AC:
5
ExAC
AF:
0.000148
AC:
18
EpiCase
AF:
0.000330
EpiControl
AF:
0.000300

ClinVar

Significance: Uncertain significance
Submissions summary: Uncertain:2
Revision: criteria provided, single submitter
LINK: link

Submissions by phenotype

LEPR-related disorder Uncertain:1
Jun 18, 2024
PreventionGenetics, part of Exact Sciences
Significance:Uncertain significance
Review Status:no assertion criteria provided
Collection Method:clinical testing

The LEPR c.430G>T variant is predicted to result in the amino acid substitution p.Val144Leu. This variant has been reported in a patient with obesity who also carries a variant in PCSK1 (Courbage et al. 2021. PubMed ID: 34097736). This variant was observed in a cohort of individuals with obesity, and in vitro functional studies showed function similar to that of wildtype levels (Supplemental Data Set, Shah et al. 2023. PubMed ID: 36864747). This variant is reported in 0.024% of alleles in individuals of European (Non-Finnish) descent in gnomAD. Although we suspect that this variant may be benign, at this time, the clinical significance of this variant is uncertain due to the absence of conclusive functional and genetic evidence.

Monogenic diabetes Uncertain:1
Nov 20, 2015
Personalized Diabetes Medicine Program, University of Maryland School of Medicine
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:research

ACMG Criteria: BP4

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.13
BayesDel_addAF
Benign
-0.54
T
BayesDel_noAF
Benign
-0.72
CADD
Benign
6.6
DANN
Benign
0.49
DEOGEN2
Benign
0.0
.;.;T;.;.;.
Eigen
Benign
-1.5
Eigen_PC
Benign
-1.5
LIST_S2
Benign
0.74
T;.;T;T;T;.
M_CAP
Benign
0.0059
T
MetaRNN
Benign
0.031
T;T;T;T;T;T
MetaSVM
Benign
-0.97
T
MutationAssessor
Benign
0.55
N;N;N;N;N;N
PhyloP100
0.16
PrimateAI
Benign
0.26
T
PROVEAN
Benign
0.15
N;N;N;N;.;N
Sift
Benign
0.99
T;T;T;T;.;T
Sift4G
Benign
1.0
T;T;T;T;T;T
Vest4
0.066
ClinPred
0.0073
T
GERP RS
-5.3
Varity_R
0.036
gMVP
0.44
Mutation Taster
=98/2
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs147667928; hg19: chr1-66038068; API